People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Adze Biotechnology Inc | — | Biotechnology | Series A | $9.8M | $60.8M | 2023 |
Kenneth J. Templin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kenneth J. Templin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kenneth Templin | 1 | 2 |
| Sidney Hopps | 1 | 2 |
| Brendan Patrick Kenny | 1 | 1 |
| Gabriel Patrick Raviv | 1 | 1 |
| G. Patrick Sage, II | 1 | 1 |
| Gloria J. Olivier | 1 | 1 |
| Richard Schuler | 1 | 1 |
| Patrick G. Sage, II | 1 | 1 |
| Gabriel G. Raviv | 1 | 1 |
| G. Patrick Sage | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.